Ask AI

Multidisciplinary Care Integration in Myelofibrosis

In these slides, the progressive course of myelofibrosis and key considerations for individualized management, including treatment goals, assessment of spleen volume and symptom burden, use and monitoring of JAK inhibitors, and the role of hematopoietic stem cell transplantation is reviewed. The module also addresses treatment-related toxicities, multidisciplinary care, and the importance of aligning therapy with disease characteristics, patient priorities, and evolving clinical needs, while highlighting clinical trial participation as an important avenue for expanding future treatment options.

MF Multidisciplinary Care

Activity Information

Released: October 26, 2026